Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Elevai Labs Inc. | CFO, Director | Common Stock | 983K | Nov 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
QLGN | Qualigen Therapeutics, Inc. | Nov 7, 2024 | 0 | $0 | 3 | Nov 15, 2024 | Director |
ELAB | Elevai Labs Inc. | Nov 13, 2023 | 0 | $0 | 3 | Jan 17, 2024 | CFO, Director |